作者：
Oliver,Quitt [1]
;
Shanshan,Luo [1]
;
Marten,Meyer [2]
;
Zhe,Xie [1]
;
Forough,Golsaz-Shirazi [3]
;
Eva,Loffredo-Verde [1]
;
Julia,Festag [1]
;
Jan Hendrik,Bockmann [4]
;
Lili,Zhao [1]
;
Daniela,Stadler [1]
;
Wen-Min,Chou [1]
;
Raindy,Tedjokusumo [1]
;
Jochen Martin,Wettengel [1]
;
Chunkyu,Ko [1]
;
Elfriede,Noeßner [1]
;
Nadja,Bulbuc [2]
;
Fazel,Shokri [3]
;
Sandra,Lüttgau [5]
;
Mathias,Heikenwälder [1]
;
Felix,Bohne [1]
;
Gerhard,Moldenhauer [5]
;
Frank,Momburg [2]
;
Ulrike,Protzer [6]
作者单位：
Institute of Virology, School of Medicine, Technical University of Munich, Helmholtz Zentrum München, Munich, Germany.
[1]
Antigen Presentation and T/NK Cell Activation Group, Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Centre, Heidelberg, Germany.
[2]
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
[3]
Institute of Virology, School of Medicine, Technical University of Munich, Helmholtz Zentrum München, Munich, Germany; German Center for Infection Research (DZIF), Munich and Hamburg Partner sites, Germany; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[4]
Department of Translational Immunology, German Cancer Research Centre, Heidelberg, Germany.
[5]
Institute of Virology, School of Medicine, Technical University of Munich, Helmholtz Zentrum München, Munich, Germany; German Center for Infection Research (DZIF), Munich and Hamburg Partner sites, Germany. Electronic address: protzer@tum.de.
[6]
DOI
10.1016/j.jhep.2021.06.022
PMID
34171437
发布时间
2022-02-08
换一批
换一批
